SHORT JAY M PHD 4

What Happened Jay M. Short, Ph.D., CEO of BioAtla, was granted a time‑based restricted stock unit (RSU) award for 430,000 shares on March 11, 2026. The award was reported as an acquisition at $0.00 (award/compensation), meaning no cash was paid by the reporting person. The RSU award vests over time subject to continued service.

Key Details

• Transaction date: March 11, 2026; reported on Form 4 filed March 12, 2026.
• Grant: 430,000 RSUs, acquisition code A, reported price $0.00.
• Vesting (per footnote): 25% vests on March 11, 2027, then 6.25% of the total shares vests on the last day of each May, August, November and February thereafter, subject to continued service.
• Shares owned after transaction: Not specified in the filing.
• Filing timeliness: Report filed the next day (appears timely).
• Footnote on ownership: The reporting person and spouse manage Himalaya Parent LLC and say they disclaim beneficial ownership of the securities except to the extent of any pecuniary interest (per footnote F2).

Context This was a compensation award (RSUs), not an open‑market purchase or sale. RSUs generally convert to actual shares only as they vest and are subject to service conditions and tax withholding; they do not necessarily indicate immediate buying or selling intent by the insider. Retail investors may note future vesting dates as potential sources of additional shares entering the market.